COP1 and Parkinson disease: Besides the PFF model, other mouse models, such as the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD model, have shown that the therapeutic immunization of Cop-1 and OVA protected dopaminergic neurons [38].